Health condition
GIST tumours
Gastrointestinal stromal tumours (GISTs) arise in the wall of the stomach or bowel and are driven by KIT or PDGFRA mutations; targeted tablets have made them one of oncology’s clearest precision-medicine successes.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key facts
The essentials at a glance.
The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.
-
Most GISTs carry KIT or PDGFRA mutations, and mutation testing directs drug choice
-
Small gastric GISTs found incidentally may need only surveillance
-
Imatinib is used after surgery for higher-risk tumours and as first-line for advanced disease
-
PDGFRA D842V-mutant GISTs do not respond to imatinib but do respond to avapritinib
Understanding the condition
What it is and what happens next.
What causes it, how it is diagnosed, and the treatment routes available in the UK.
What it is and how it feels
GISTs develop from the pacemaker cells of the gut and range from millimetre-scale incidental findings to large bleeding tumours presenting with anaemia or abdominal discomfort. Risk is estimated from size, location and how actively the cells are dividing, which separates tumours cured by surgery alone from those likely to recur and deserving of adjuvant drug therapy.
Diagnosis and treatment routes
The transformation came with imatinib: advanced GIST, once untreatable, is now managed for years with tablets, and three years of adjuvant imatinib is standard after resection of high-risk tumours. Mutation profiling is not optional - it identifies the imatinib-resistant PDGFRA D842V group and the rare SDH-deficient GISTs of younger patients, each needing a different strategy. Later lines include sunitinib, regorafenib and ripretinib. If you are waiting for results or want a second opinion on a proposed plan, a private consultation with a specialist who treats this condition regularly can usually be arranged quickly, and most will review your existing scans, biopsy reports and MDT correspondence.
Seeing a specialist
Who to see, and how quickly you can be seen.
The specialist for this condition is usually a consultant oncologist. Your GP can refer you on the NHS, or you can arrange a private consultation directly.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.
Frequently asked
Common questions about GIST tumours.
Quick, plain-English answers to what people ask us most.
-
What does GIST tumours mean?
GIST tumours is a condition your doctor may diagnose based on your symptoms, medical history and, where needed, examination or test results. Understanding exactly how it applies to your situation is best done with a clinician who can look at your full picture rather than relying on general information alone.
-
What are the risk factors for GIST tumours?
GIST tumours can arise from several different underlying mechanisms, and in many cases more than one factor contributes. Identifying likely causes usually forms part of the initial specialist work-up.
-
What are the symptoms of GIST tumours?
Symptoms of GIST tumours vary from person to person and can range from mild and easily missed to significant enough to affect daily life. Because overlapping conditions can produce similar symptoms, a clinical assessment is the most reliable way to confirm what's actually going on.
-
How dangerous is GIST tumours?
GIST tumours is a serious diagnosis that needs prompt, specialist-led assessment and a clear treatment plan. Outcomes depend heavily on factors such as how early it's found and how it responds to treatment, which is why timely investigation matters.
-
Is GIST tumours hereditary?
In most cases GIST tumours isn't straightforwardly inherited, though family history can sometimes be a relevant background factor. A clinician can help you understand whether it's worth mentioning relatives' health when being assessed.
-
Is GIST tumours treatable?
Treatment for GIST tumours depends on the stage and type at diagnosis, and can include surgery, medical therapy, radiotherapy or a combination, sometimes with curative intent and sometimes focused on control and quality of life. A multidisciplinary specialist team is best placed to explain realistic goals for your specific case.
-
How is GIST tumours treated?
Treatment for GIST tumours is usually built around the severity of your symptoms and any underlying cause found on assessment, and may involve lifestyle measures, medication, physiotherapy or, in some cases, a procedure. Your specialist will discuss the pros and cons of each option with you before agreeing a plan.
-
What's the outlook for GIST tumours?
The outlook for GIST tumours varies widely depending on the underlying cause, how early it's diagnosed, and how it responds to treatment. Many people see significant improvement with appropriate care, and your specialist can give you a more personalised timeframe once they've reviewed your case.
-
When is surgery needed for GIST tumours?
Whether surgery plays a role in treating GIST tumours depends on factors such as stage, location and overall health, and is decided by a multidisciplinary team weighing up the likely benefits against the risks. Non-surgical options are often used alongside or instead of surgery depending on the individual case.
-
When should I see a doctor about GIST tumours, and how quickly can I be seen privately?
It's worth seeking medical advice if symptoms of GIST tumours are persistent, worsening, or affecting your daily life, rather than waiting for them to resolve on their own. NHS routine referrals for this kind of assessment can take anywhere from around 20 to 45+ weeks, whereas private consultants typically offer an appointment within about two weeks.